AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $162,000 | +39.7% | 12,239 | +151.6% | 0.00% | 0.0% |
Q2 2016 | $116,000 | +16.0% | 4,864 | +13.8% | 0.00% | 0.0% |
Q1 2016 | $100,000 | +3.1% | 4,275 | +33.6% | 0.00% | 0.0% |
Q4 2015 | $97,000 | -41.6% | 3,201 | -23.4% | 0.00% | 0.0% |
Q3 2015 | $166,000 | +137.1% | 4,177 | +312.3% | 0.00% | 0.0% |
Q2 2015 | $70,000 | -82.6% | 1,013 | -86.3% | 0.00% | -66.7% |
Q1 2015 | $403,000 | +1579.2% | 7,375 | +1212.3% | 0.00% | – |
Q4 2014 | $24,000 | +14.3% | 562 | -15.6% | 0.00% | – |
Q3 2014 | $21,000 | +75.0% | 666 | +10.6% | 0.00% | – |
Q2 2014 | $12,000 | 0.0% | 602 | 0.0% | 0.00% | – |
Q1 2014 | $12,000 | -20.0% | 602 | -0.8% | 0.00% | – |
Q4 2013 | $15,000 | -65.1% | 607 | -69.7% | 0.00% | – |
Q3 2013 | $43,000 | +79.2% | 2,002 | +81.8% | 0.00% | – |
Q2 2013 | $24,000 | – | 1,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |